young
children
fever
appar
focu
infect
selflimit
viral
infect
resolv
without
treatment
associ
signific
sequela
howev
small
proport
young
children
fever
appear
serious
ill
may
seen
earli
cours
bacteri
infect
could
progress
bacteremia
mening
despit
numer
studi
attempt
identifi
febril
child
appear
well
seriou
infect
assess
effect
potenti
intervent
clear
answer
emerg
studi
show
parent
usual
will
physician
assum
small
risk
seriou
advers
outcom
exchang
avoid
shortterm
advers
effect
invas
diagnost
test
antimicrobi
treatment
best
approach
treatment
febril
child
combin
inform
estim
risk
care
clinic
evalu
followup
child
judici
use
diagnost
test
list
microb
caus
fever
children
extens
rel
import
specif
agent
vari
age
season
associ
symptom
goal
chapter
assist
identifi
febril
child
seriou
bacteri
infect
sbi
tabl
show
common
caus
sbi
children
younger
month
divis
month
absolut
consider
overlap
exist
receipt
vaccin
typic
administ
month
also
reduc
risk
sbi
certain
virus
notabl
herp
simplex
influenza
enterovirus
caus
seriou
infect
neonat
mimick
septicemia
begin
fever
appar
focu
infect
less
seriou
viral
infect
common
caus
fever
children
age
children
month
age
bacteri
infect
appar
focu
caus
streptococcu
pneumonia
unimmun
children
neisseria
meningitidi
salmonella
spp
infect
often
associ
symptom
gastroenter
univers
administr
pneumococc
haemophilu
influenza
type
b
hib
conjug
vaccin
hib
becom
rare
incid
infect
pneumonia
fallen
substanti
common
caus
invas
bacteri
infect
children
staphylococcu
aureu
usual
associ
identifi
focal
infect
risk
seriou
bacteri
infect
vari
age
although
longitudin
studi
shown
children
brought
medic
attent
fever
first
month
life
greater
proport
febril
infant
seriou
bacteri
infect
older
children
risk
greatest
immedi
neonat
period
first
month
life
risk
heighten
infant
born
prematur
prospect
studi
conduct
investig
univers
rochest
factor
identifi
indic
low
risk
seriou
bacteri
infect
febril
infant
younger
month
among
infant
born
term
perinat
complic
underli
diseas
receiv
antibiot
hospit
fever
possibl
septicemia
consid
unlik
seriou
bacteri
infect
fulfil
follow
criteria
clinic
evid
infect
ear
skin
bone
joint
white
blood
cell
wbc
count
less
band
cellsmm
normal
urinalysi
result
infant
seriou
bacteri
infect
ie
salmonella
gastroenter
none
bacteremia
contrast
among
infant
meet
criteria
seriou
bacteri
infect
p
bacteremia
p
sediment
rate
creactiv
protein
procalcitonin
morpholog
chang
peripher
blood
neutrophil
quantit
cultur
blood
clinic
scale
develop
help
identifi
febril
child
seriou
ill
unfortun
test
suffici
sensit
posit
predict
valu
ppv
npv
clinic
use
individu
patient
era
conjug
vaccin
hib
pneumonia
sever
studi
examin
risk
bacteremia
among
children
temperatur
higher
fever
wbc
count
least
ppv
test
bacteremia
current
era
low
incid
unconfirm
predict
valu
wbc
remain
pathogen
laboratori
test
longer
justifi
make
laboratoryconfirm
diagnosi
viral
infect
significantli
reduc
likelihood
febril
infant
concomit
bacteri
infect
except
uti
current
hold
true
influenza
rsv
enteroviru
futur
like
true
mani
respiratori
virus
eg
human
metapneumoviru
parainfluenza
viru
coronaviru
diagnos
multiplex
polymeras
chain
reaction
pcr
technolog
one
studi
show
incorpor
viral
diagnost
initi
evalu
febril
infant
reduc
length
hospit
healthcar
cost
although
singl
correct
approach
manag
febril
infant
without
local
sign
appear
well
studi
provid
data
base
inform
decis
made
gener
agreement
febril
children
young
ie
various
consid
younger
month
age
manag
differ
older
children
substanti
greater
risk
seriou
infect
young
infant
fever
difficulti
assess
degre
well
accur
pediatrician
approach
manag
case
conserv
clinician
adher
protocol
treat
young
infant
fever
appar
focu
infect
broadspectrum
antimicrobi
agent
administ
intraven
hospit
result
cultur
blood
urin
cerebrospin
fluid
csf
known
although
perceiv
safe
approach
incur
consider
financi
cost
risk
iatrogen
complic
diagnost
misadventur
associ
hospit
risk
includ
error
type
dosag
drug
complic
venou
cannul
eg
phlebiti
slough
skin
nosocomi
infect
hospit
young
infant
major
disrupt
famili
may
potenti
develop
vulner
child
syndrom
investig
found
select
young
infant
fever
treat
expectantli
without
hospit
consequ
mani
expert
think
febril
infant
week
age
appar
focu
infect
appear
well
laboratorydocu
viral
infect
treat
without
addit
laboratori
test
hospit
provid
care
followup
ensur
other
prefer
confirm
laboratori
criteria
predict
low
risk
sometim
includ
normal
csf
analysi
result
provid
observ
patient
close
without
give
antimicrobi
therapi
other
treat
infant
day
singl
daili
dose
ceftriaxon
mg
kg
administ
parenter
await
result
blood
urin
csf
cultur
either
approach
care
vigil
defens
antimicrobi
agent
administ
cultur
blood
urin
csf
obtain
rapid
test
specif
viral
pathogen
wide
avail
aid
decis
manag
patient
reduc
durat
hospit
elimin
need
febril
infant
low
risk
seriou
bacteri
infect
adequ
home
observ
followup
ensur
hospit
observ
without
antimicrobi
treatment
child
appear
well
reason
avoid
advers
side
effect
antimicrobi
agent
intraven
cannul
shorten
durat
hospit
save
money
without
place
child
signific
risk
complic
mani
studi
larg
corrobor
result
rochest
studi
although
investig
use
slightli
differ
criteria
defin
young
febril
infant
low
risk
seriou
bacteri
infect
investig
exclud
children
younger
month
old
found
risk
seriou
bacteri
ill
group
defin
low
risk
low
approxim
young
febril
infant
urinari
tract
infect
uti
larg
due
escherichia
coli
group
overal
concomit
bacteremia
mening
metaanalysi
studi
febril
children
younger
month
risk
seriou
bacteri
ill
bacteremia
mening
respect
highrisk
infant
respect
lowrisk
infant
neg
predict
valu
npv
seriou
bacteri
ill
among
infant
fulfil
lowrisk
criteria
rang
npv
bacteremia
mening
although
risk
seriou
bacteri
infect
high
among
febril
infant
younger
month
age
appar
focu
infect
clinic
laboratori
assess
identifi
slightli
infant
low
risk
observ
studi
infant
younger
month
age
fever
greater
treat
practition
report
part
pediatr
research
offic
set
network
found
hospit
practition
individu
manag
reli
clinic
judgment
guidelin
follow
episod
outcom
children
excel
guidelin
follow
outcom
would
improv
would
substanti
laboratori
test
perform
hospit
risk
seriou
bacteri
ill
young
infant
fallen
due
mark
reduct
earlyonset
group
b
streptococc
infect
effect
peripartum
antimicrobi
prophylaxi
pregnant
women
posit
screen
test
result
colon
group
b
streptococcu
febril
children
younger
month
age
identifi
viral
infect
influenza
respiratori
syncyti
viru
rsv
enterovirus
risk
seriou
bacteri
infect
uti
fall
almost
zero
concern
occult
bacteremia
febril
children
month
month
age
studi
perform
era
show
children
month
age
older
fever
appear
toxic
appar
focu
infect
bacteremia
often
due
pneumonia
occasion
due
hib
n
meningitidi
instanc
seriou
focal
infect
mening
develop
children
occult
bacteremia
concern
progress
focal
infect
result
protocol
develop
identifi
interven
infant
high
risk
protocol
emphas
routin
blood
cultur
empir
antibiot
administr
mani
febril
children
age
group
practic
discount
sever
fact
first
children
occult
bacteremia
transient
infect
recov
without
antimicrobi
therapi
without
develop
seriou
complic
eg
mening
septic
shock
second
risk
mening
complic
occult
bacteremia
vari
bacteri
speci
n
meningitidi
hib
pneumonia
third
univers
vaccin
hib
led
elimin
vaccin
infant
concern
occult
bacteremia
subsequ
use
conjug
pneumococc
vaccin
elimin
almost
case
occult
bacteremia
risk
uti
wellappear
febril
children
age
group
chang
significantli
year
sever
studi
shown
rate
uti
vari
among
differ
popul
eg
girl
vs
boy
uncircumcis
vs
circumcis
within
age
group
vari
height
durat
fever
uti
consid
potenti
sourc
sbi
patient
variou
diagnost
test
quantifi
risk
bacteremia
complic
assess
includ
wbc
count
differenti
count
microscop
examin
buffi
coat
blood
erythrocyt
focu
found
child
appear
toxic
diagnost
test
indic
routin
parent
instruct
look
sign
seriou
problem
develop
eg
persist
irrit
lethargi
inattent
environ
serial
observ
plan
permit
subsequ
clinic
laboratori
evalu
antimicrobi
treatment
indic
practition
encount
febril
child
older
month
age
unimmun
partial
immun
aggress
plan
evalu
manag
may
warrant
chapter
focus
invas
bacteri
infect
particularli
bacteremia
caus
fever
without
appar
focu
although
seriou
ill
autoimmun
diseas
inflammatori
bowel
diseas
manifest
fever
without
focu
infect
rare
come
attent
persist
recurr
fever
see
chapter
refer
avail
onlin
wwwexpertconsultcom
infant
fever
younger
month
hospit
treat
antimicrobi
therapi
without
acyclovir
herp
simplex
viru
although
select
instanc
hospit
without
antimicrobi
treatment
outpati
manag
laboratori
evalu
includ
csf
analysi
may
reason
decis
made
administ
antimicrobi
agent
intraven
ampicillin
mgkg
per
day
everi
hour
plu
gentamicin
mgkg
per
day
everi
hour
thirdgener
cephalosporin
eg
ceftriaxon
mgkg
per
day
one
dose
cefotaxim
mgkg
per
day
everi
hour
could
chosen
ampicillin
gentamicin
wellestablish
combin
narrow
spectrum
antimicrobi
activ
ceftriaxon
excel
effect
group
b
streptococcu
listeria
monocytogen
mani
enter
gramneg
rod
rise
incid
ampicillinresist
e
coli
rariti
listeriosi
recent
larg
studi
regimen
thirdgener
cephalosporin
without
ampicillin
offer
coverag
infant
bacteremia
mening
uti
due
ampicillinresist
e
coli
studi
directli
assess
rel
risk
benefit
either
regimen
initi
antimicrobi
treatment
regimen
cultur
blood
urin
obtain
urethr
catheter
suprapub
aspir
bladder
csf
obtain
children
month
age
older
appear
well
appar
focu
infect
evalu
clinic
without
laboratori
test
treatment
antimicrobi
agent
except
examin
urin
current
conjug
vaccin
era
blood
cultur
isol
substanti
like
contamin
pathogen
substanti
evid
suggest
obtain
blood
cultur
routin
children
littl
impact
outcom
although
falseposit
blood
cultur
result
lead
substanti
unnecessari
cost
follow
approach
seem
appropri
febril
child
care
assess
focu
infect
includ
uti
focu
found
child
treat
accord
like
pathogen
child
appear
toxic
appropri
cultur
diagnost
test
perform
antimicrobi
treatment
usual
cefotaxim
mgkg
per
day
divid
dose
everi
hour
ceftriaxon
mgkg
daili
initi
physician
add
vancomycin
mgkg
per
day
divid
dose
everi
hour
children
hospit
